Updated on 2 May 2012
Angel has been at the forefront of developing new stem cells therapies developed in research labs into products for commercialization. Angel provides small scale manufacturing facility and test the strengths of these lines developed in laboratories.
It is also a major contract manufacturer of recombinant proteins, antibody and bacteriophages.
(The writer was in Edinburgh, Scotland, at the invitation of Scottish Developing International)
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
